Catherine Novack
Stock Analyst at Jones Trading
(n/a)
# 3,968
Out of 4,962 analysts
20
Total ratings
n/a
Success rate
-30.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $13.00 | +130.77% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $6.60 | +339.39% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.52 | +1,064.82% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.58 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $50.13 | -10.23% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.26 | +387.80% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $20.02 | +549.35% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.90 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $9.94 | +60.97% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.72 | +276.34% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.08 | +525.00% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.00 | +42.86% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.79 | +688.53% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.00 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.21 | +7,139.82% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $13.00
Upside: +130.77%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $6.60
Upside: +339.39%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.52
Upside: +1,064.82%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.58
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $50.13
Upside: -10.23%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.26
Upside: +387.80%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $20.02
Upside: +549.35%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.90
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $9.94
Upside: +60.97%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.72
Upside: +276.34%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.08
Upside: +525.00%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $7.00
Upside: +42.86%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $2.79
Upside: +688.53%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.00
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.21
Upside: +7,139.82%